Weekly vs 3-weekly cisplatin: a retrospective cohort study

被引：0
|
作者：
Saerens, Michael [1 ,2 ]
Van den Broeck, Alexander [2 ]
de Weghe, Geertrui Van [2 ]
Wouter, Huvenne [3 ,4 ]
Peter, Tomassen [3 ,4 ]
Wouter, Bauters [5 ]
Vermassen, Tijl [1 ,2 ]
Sarah, Deschuymer [6 ,7 ]
Rottey, Sylvie [1 ,2 ,8 ]
Duprez, Frederic [6 ,7 ]
机构：
[1] Ghent Univ Hosp, Med Oncol, Ghent, Belgium
[2] Univ Ghent, Basic & Appl Med Sci, Ghent, Belgium
[3] Ghent Univ Hosp, Head & Neck Surg, Ghent, Belgium
[4] Univ Ghent, Head & Skin, Ghent, Belgium
[5] Ghent Univ Hosp, Radiol, Ghent, Belgium
[6] Ghent Univ Hosp, Radiotherapy, Ghent, Belgium
[7] Univ Ghent, Human Struct & Repair, Ghent, Belgium
[8] Ghent Univ Hosp, Drug Res Unit, Ghent, Belgium
来源：
RADIOTHERAPY AND ONCOLOGY | 2024年 / 192卷
关键词：
Chemoradiotherapy; cisplatin; toxicity;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
229
引用
收藏
页码：S280 / S283
页数：5
相关论文
共 50 条
  • [41] WEEKLY PACLITAXEL VERSUS THE STANDARD 3-WEEKLY SCHEDULE IN PATIENTS WITH NON-SMALL CELL LUNG CANCER
    Halim, I. Abdel
    El-Ashry, M.
    El-Sadda, W.
    Temraz, S.
    ANNALS OF ONCOLOGY, 2012, 23 : 398 - 398
  • [42] Can advanced non-small-cell lung cancer be treated with weekly instead of 3-weekly docetaxel?
    Giorgio V Scagliotti
    Nature Clinical Practice Oncology, 2006, 3 : 294 - 295
  • [43] Can advanced non-small-cell lung cancer be treated with weekly instead of 3-weekly docetaxel?
    Scagliotti, G. V.
    NATURE CLINICAL PRACTICE ONCOLOGY, 2006, 3 (06): : 294 - 295
  • [44] Premedication for prophylaxis of hypersensitivity reactions (HSR) after weekly or 3-weekly paclitaxel (ptx): a comprehensive literature review
    Dewaele, Elien
    Specenier, Pol
    ACTA CLINICA BELGICA, 2016, 71 : 13 - 13
  • [45] Comparison between weekly versus 3-weekly paclitaxel in combination with carboplatin as neoadjuvant chemotherapy in advanced ovarian cancer
    Kim, Yoo-Na
    Lee, Yong Jae
    Lee, Jung-Yun
    Nam, Eun Ji
    Kim, Sang Wun
    Kim, Sunghoon
    Kim, Young Tae
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2020, 31 (02)
  • [46] Premedication prophylaxis of hypersensitivity reactions (HSR) after weekly or 3-weekly paclitaxel (ptx): a comprehensive literature review
    Dewaele, E.
    Specenier, P.
    EUROPEAN JOURNAL OF CANCER, 2017, 72 : S165 - S165
  • [47] JCOG1008: Phase II/III Trial of postoperative chemoradiotherapy comparing 3-weekly cisplatin with weekly cisplatin in high-risk patients with squamous cell carcinoma of head and neck
    Kiyota, Naomi
    ANNALS OF ONCOLOGY, 2015, 26 : 14 - 14
  • [48] Phase II study of weekly paclitaxel plus 24-h continuous infusion 5-fluorouracil, folinic acid and 3-weekly cisplatin for the treatment of patients with advanced gastric cancer
    Honecker, F
    Kollmannsberger, C
    Quietzsch, D
    Haag, C
    Schroeder, M
    Spott, C
    Hartmann, JT
    Baronius, W
    Hempel, V
    Kanz, L
    Bokemeyer, C
    ANTI-CANCER DRUGS, 2002, 13 (05) : 497 - 503
  • [49] Comparison of Weekly and 3-weekly Cisplatin-based Chemoradiation Therapy Regimens for the Treatment of Patients With Stage III/IV Squamous Cell Head-and-Neck Cancer
    Newcomb, M.
    Kramer, S.
    Hessler, J. D.
    Grecula, J. C.
    Gillison, M. L.
    Neki, A.
    Siddiqui, F.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S471 - S471
  • [50] Weekly vs. tri-weekly cisplatin based chemoradiation in carcinoma cervix: a prospective randomized study of toxicity and compliance
    Katke, Aradhana
    Nanda, R.
    Thejaswini, B.
    Pasha, Tanveer
    Giri, G., V
    Babu, Govind
    Pawar, Yashwant
    REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 2021, 26 (06) : 948 - 954
12345